Indeed, in patient-derived glioma stem cell lines and established human glioma lines, TTF treatment induced formation of cytosolic micronuclei clusters and activation of type I IFNs in an AIM2- and STING-dependent manner (68). This evidence concerns the gene AIM2 and central nervous system cancer.